Article Sidebar
Published:
May 29, 2022Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Isolation of a pentacyclic triterpenoid from the antiplasmodial bioactive fraction of Nauclea latifolia (Sm) roots
Abstract
Purpose: To research the antiplasmodial property of aqueous extract, fractions, and residue of Nauclea latifolia roots and to isolate the components responsible for the antiplasmodial activity.
Methods: Roots of N. latifolia were macerated with distilled water; the extract was obtained, successively partitioned with ethyl acetate and butanol. The extract, fractions, and the residue obtained were evaluated for their in vivo antiplasmodial activity and compared with amodiaquine and artesunate. The residue (which exhibited the best therapeutic index) was subjected to column and thin layer chromatography to isolate its components. Purification led to the isolation of betulinic acid, which was characterized with the aid of spectroscopic techniques (1H, 13C NMR, and EI-MS).
Results: The residue significantly inhibited parasite growth from 42.8 % (D2) to 77.6 % (D5). Therefore, residue exhibited the highest therapeutic index against Plasmodium berghei in the three in vivo antiplasmodial (prophylactic, suppressive, and curative) models and it compared favourably with amodiaquine (80.5 %) and artesunate (85.9 %). The major component of the residue was betulinic acid.
Conclusion: The results validate the antiplasmodial claims of the roots of N. latifolia in folkloric medicine, and demonstrated that the isolate has a high therapeutic index in this regard. Further investigations, however, are required to determine the clinical efficacy and safety of the compound/isolate.
